ArticleThe Lancet. Rheumatology2023
Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus.
Ioannis ParodisPubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it